Geographical Representativeness of Published and Ongoing Randomized Controlled Trials: The Example of Tobacco Consumption and HIV Infection
2011

Geographical Representativeness of RCTs on Tobacco and HIV

Sample size: 1086 publication Evidence: high

Author Information

Author(s): Ahmad Nizar, Boutron Isabelle, Dechartres Agnes, Durieux Pierre, Ravaud Philippe, Chêne Geneviève

Primary Institution: INSERM, U738, Paris, France

Hypothesis

This study aimed to compare where research is conducted to where research is needed for tobacco consumption and HIV infection.

Conclusion

The study found significant underrepresentation of low- and middle-income countries in research related to tobacco use and HIV infection.

Supporting Evidence

  • Only 4% of RCTs on tobacco use were conducted in low- and middle-income countries.
  • 31% of RCTs on HIV were conducted in low- and middle-income countries, despite these countries representing 99% of HIV-related mortality.
  • Most ongoing trials for both tobacco and HIV are performed in high-income countries.

Takeaway

The research shows that most studies on tobacco and HIV are done in rich countries, even though most deaths from these issues happen in poorer countries.

Methodology

The study analyzed randomized controlled trials included in Cochrane systematic reviews and ongoing trials registered in the WHO-ICTRP.

Potential Biases

The results may underestimate ongoing trials in low- and middle-income countries due to reliance on registered data.

Limitations

The study focused only on tobacco use and HIV infection, which may not represent other health issues.

Participant Demographics

The study included trials from both high-income and low- and middle-income countries.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016878

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication